CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid‑In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		119,426,064
Beginning balance at Dec. 31, 2021	$ 738,426	$ 119	$ 913,581	$ (7,866)	$ (167,408)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		211,200
Exercise of stock options	1,197		1,197
Vesting of restricted stock units (in shares)		22,191
Share‑based compensation	16,010		16,010
Foreign currency translation adjustments	(8,083)			(8,083)
Net loss	(25,629)				(25,629)
Ending balance (in shares) at Mar. 31, 2022		119,659,455
Ending balance at Mar. 31, 2022	721,921	$ 119	930,788	(15,949)	(193,037)
Beginning balance (in shares) at Dec. 31, 2022		123,170,172
Beginning balance at Dec. 31, 2022	701,338	$ 123	1,049,875	(39,951)	(308,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		367,171
Exercise of stock options	2,723		2,723
Vesting of restricted stock units (in shares)		370,146
Vesting of restricted stock units	1	$ 1
Share‑based compensation	19,550		19,550
Foreign currency translation adjustments	6,047			6,047
Net loss	(24,200)				(24,200)
Ending balance (in shares) at Mar. 31, 2023		123,907,489
Ending balance at Mar. 31, 2023	$ 705,459	$ 124	$ 1,072,148	$ (33,904)	$ (332,909)